NCIt definition : A humanized monoclonal antibody directed against the Notch-1 receptor with potential
antineoplastic activity. Upon administration, brontictuzumab binds to Notch-1 on the
cell surface, thereby inhibiting Notch-mediated signaling and tumor cell proliferation.
Notch 1, a type 1 transmembrane protein belonging to the Notch family, functions as
a receptor for membrane bound ligands and has various roles during development; dysregulated
Notch signaling is associated with increased cell growth and chemoresistance in cancers.;
UNII : UNY2TQA40E;
CAS number : 1447814-75-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1447814-75-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;